A phase II study of peripheral blood stem cell (PBSC) mobilization using stem cell factor (SCF), filgrastin (G-CSF), and cyclophosphamide (CY) in patients at high risk for mobilization failure.

被引：0
|
作者：
Chen, CI [1 ]
Nagy, T [1 ]
Yi, QL [1 ]
Keating, A [1 ]
Crump, M [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2883
引用
收藏
页码：788A / 788A
页数：1
相关论文
共 50 条
  • [41] Peripheral stem cell mobilization with chemotherapy and G-CSF in chronic myeloid leukemia
    Boque, C
    Petit, J
    Sarra, J
    Berlanga, J
    Ferra, C
    delaBanda, E
    Espanol, I
    Munoz, J
    Callis, M
    Aventin, A
    Torrico, C
    Amill, B
    Cancelas, J
    Garcia, J
    Granena, A
    BLOOD, 1995, 86 (10) : 3742 - 3742
  • [42] High dose G-CSF and scf mobilization protocol markedly improves CD34+ cell yield in peripheral blood stem cell (PBSC) apheresis in non human primate (NHP).
    Jie, T
    Harmon, JV
    Kirchhof, N
    Clemmings, SM
    Aasheim, T
    Graham, M
    Eastlund, T
    Hering, BJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 220 - 220
  • [43] PERIPHERAL-BLOOD STEM-CELL MOBILIZATION AFTER STEM-CELL FACTOR (SCF) OR G-CSF TREATMENT - RAPID ENRICHMENT FOR STEM AND PROGENITOR CELLS USING THE CEPRATETM IMMUNOAFFINITY SEPARATION SYSTEM
    HEIMFELD, S
    ANDREWS, R
    ZSEBO, K
    FOGARTY, B
    MCGUIRE, K
    WILLIAMS, S
    BERENSON, R
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 748 - 748
  • [44] Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma
    Buehler, Selina
    Akhoundova, Dilara
    Jeker, Barbara
    Legros, Myriam
    Seipel, Katja
    Daskalakis, Michael
    Bacher, Ulrike
    Pabst, Thomas
    CANCERS, 2023, 15 (02)
  • [45] Cyclophosphamide or plerixafor and G-CSF for stem cell mobilization: initial cost comparison analysis
    Jagasia, M.
    Pickard, S.
    Chen, H.
    Dixon, S.
    Savani, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S24 - S24
  • [46] Effects of Mobilization with Granulocyte Colony Stimulating Factor (G-CSF) and Plerixafor On Lymphocyte Subsets in Autologous Peripheral Blood Stem Cell (PBSC) Apheresis Products
    Elquza, Emad
    Spier, Catherine
    Fiederlein, Roger
    Salamon, David
    Yeager, Andrew M.
    BLOOD, 2009, 114 (22) : 843 - 844
  • [47] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [48] PLERIXAFOR GIVEN "JUST IN TIME" FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION OF PATIENTS WITH SUBOPTIMAL RESPONSE TO G-CSF
    Horwitz, M.
    Khan, T.
    Long, G.
    Gasparetto, C.
    Sullivan, K.
    Chute, J.
    Rizzieri, D.
    Drago, S.
    Chao, N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S208 - S208
  • [49] FACTORS PREDICTING PERIPHERAL BLOOD STEM CELL (PBSC) MOBILIZATION WITH PLERIXAFOR IN MULTIPLE MYELOMA PATIENTS WHO HAD INADEQUATE MOBILIZATION WITH G-CSF.
    Bakeer, M. S.
    Zubair, A.
    Roy, V.
    CYTOTHERAPY, 2019, 21 (05) : S59 - S60
  • [50] OPTIMAL PERIPHERAL-BLOOD STEM-CELL (PBSC) MOBILIZATION WITH GM-CSF OR G-CSF NECESSITATES CHEMOTHERAPY PRIMING - A STUDY OF GM-CSF OR G-CSF ALONE COMPARED TO GM-CSF OR G-CSF PLUS CYTOXAN (CY)
    KOUIDES, PA
    ABBOUD, CN
    KOUIDES, RW
    FREDIANI, KE
    BELANGER, T
    DIPERSIO, JF
    BLOOD, 1993, 82 (10) : A634 - A634
12345